MBX Biosciences, Inc. (MBX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$61.72+0.49%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · MBX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Operating Expenses & Income | |||||
| R&D Expenses | 88.5 | 79.2 | 57.4 | 28.5 | — |
| Operating Income | (117.9) | (98.1) | (68.2) | (35.3) | — |
| Earnings from Continuing Operations | |||||
| EBT, Incl. Unusual Items | — | (87.0) | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | — |
| Net Income | |||||
| Net Income | (104.3) | (87.0) | (61.9) | (32.6) | — |
| Per Share | |||||
| Basic EPS | (2.19) | (2.38) | (5.82) | (31.96) | — |
| Diluted EPS | (2.19) | (2.38) | (5.82) | (31.96) | — |
| Basic Weighted Avg Shares | 47.7 | 36.5 | 10.6 | 1.0 | — |
| Diluted Weighted Avg Shares | 47.7 | 36.5 | 10.6 | 1.0 | — |
| Supplemental | |||||
| EBIT | (117.9) | (98.1) | (68.2) | (35.3) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.